Dendritic cell-derived exosomes from PDT-treated glioma cells enhance antitumor immunity as a subcellular vaccine
Fang Wang, Shuai Ma, Zhihui Liu, Mengzhao Feng, Dengpan Song, Mengyuan Li, Yuan An, Kaiyuan Zhang, Yan Du, Shaoshan Hu, Xinbin Guo, Fuyou Guo, Han Liu · 2026
Read Dendritic cell-derived exosomes from PDT-treated glioma cells enhance antitumor immunity as a subcellular vaccine by Fang Wang, Shuai Ma, Zhihui Liu, Mengzhao Feng, Dengpan Song, Mengyuan Li, Yuan An, Kaiyuan Zhang, Yan Du, Shaoshan Hu, Xinbin Guo, Fuyou Guo, Han Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13214114.txt.
Description
BackgroundGlioma is a highly aggressive brain tumor with a poor prognosis. Photodynamic therapy (PDT) induces antitumor immunity, a key mechanism of its efficacy. Dendritic cell-derived exosomes (Dexs) are crucial for tumor antigen presentation and T-cell activation. Dexs represent a promising cell-free strategy for cancer immunotherapy. Understanding the role of Dexs in PDT-induced immunity may enhance PDT efficacy.
Catalog record
| CREATOR | Fang Wang, Shuai Ma, Zhihui Liu, Mengzhao Feng, Dengpan Song, Mengyuan Li, Yuan An, Kaiyuan Zhang, Yan Du, Shaoshan Hu, Xinbin Guo, Fuyou Guo, Han Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |